SCHEMBL9547482

SCHEMBL9547482

CC(=O)CC1(O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17446962 0.89
SCHEMBL13545394 0.87 CYP2C19 (0.47)
SCHEMBL25447009 0.83 KDM4E (0.36)
SCHEMBL27685278 0.81 BDKRB2 (0.38)
SCHEMBL24896647 0.81 KDM4E (0.35)
SCHEMBL28219846 0.78 CYP2D6 (0.32)
SCHEMBL25612020 0.76 CYP2C19 (0.36)
SCHEMBL28199614 0.76 ALDH1A1 (0.30)
SCHEMBL15460034 0.73 ALDH1A1 (0.37)
SCHEMBL20077536 0.73 POLB (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024057013-A1 NLRP3 MODULATORS EXSCIENTIA AI LIMITED (GB) 2024-03-21 WO disclosed
US-9493485-B2 Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof IMAGO PHARMACEUTICALS, INC. (US) 2016-11-15 US disclosed
US-20160272654-A1 SPIROCYCLIC DIHYDRO-THIAZINE AND DIHYDRO-OXAZINE BACE INHIBITORS, AND COMPOSITIONS AND USES THEREOF IMAGO PHARMACEUTICALS, INC. (US) 2016-09-22 US disclosed
US-20150307518-A1 SPIROCYCLIC DIHYDRO-THIAZINE AND DIHYDRO-OXAZINE BACE INHIBITORS, AND COMPOSITIONS AND USES THEREOF ELAN PHARMACEUTICALS, INC. 2015-10-29 US disclosed
US-20150087826-A1 SPIROCYCLIC DIGYDRO-THIAZINE AND DIHYDRO-OXAZINE BACE INHIBITORS, AND COMPOSITIONS AND USES THEREOF XU YING-ZI (US) 2015-03-26 US disclosed
US-20150087825-A1 SPIROCYCLIC DIGYDRO-THIAZINE AND DIHYDRO-OXAZINE BACE INHIBITORS, AND COMPOSITIONS AND USES THEREOF XU YING-ZI (US) 2015-03-26 US disclosed
EP-0226254-B1 Process for obtaining non informational substantially pure polydesoxyribonucleotides having biologic activities, and respective product FARMIGEA SPA (IT) 1993-12-08 EP disclosed